Review: taking Allegra and Requip xl together


Summary

Drug interactions are reported among people who take Allegra and Requip xl together. This review analyzes the effectiveness and drug interactions between Allegra and Requip xl. It is created by eHealthMe based on reports of 258 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Allegra and Requip xl >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Allegra

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Allegra 27,014 users)

Requip Xl

Requip xl has active ingredients of ropinirole hydrochloride. It is often used in parkinson's disease. (latest outcomes from Requip xl 772 users)

On Aug, 25, 2016

258 people who take Allegra, Requip Xl are studied.


Number of reports submitted per year:

Allegra and Requip xl drug interactions.

Drug effectiveness over time:

Allegra:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 33.0% - (1 of 3 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Requip Xl:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 75.0% - (3 of 4 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Allegra:
  • female: 16.0% - (1 of 6 people)
  • male: 60.0% - (3 of 5 people)
Requip Xl:
  • female: 100.0% - (6 of 6 people)
  • male: 40.0% - (2 of 5 people)

Drug effectiveness by age:

Allegra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 25.0% - (1 of 4 people)
  • 60+: 40.0% - (2 of 5 people)
Requip Xl:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 100.0% - (4 of 4 people)
  • 60+: 60.0% - (3 of 5 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • asthenia
  • blood pressure fluctuation
  • alcohol use
  • blood glucose increased
  • cholestasis
  • drug toxicity
  • dyskinesia
  • eating disorder
  • inflammation
1 - 6 months:
  • emotional distress
  • depression
  • hypersexuality
  • obsessive-compulsive personality disorder
  • pathological gambling
  • suicidal ideation
  • dizziness
  • vomiting
  • abdominal pain upper
  • alopecia
6 - 12 months:
  • anxiety
  • insomnia
  • glaucoma
1 - 2 years:
  • anhedonia
  • flat affect
  • drug ineffective
2 - 5 years:
  • anxiety
  • insomnia
  • bruxism
  • compulsions
  • compulsive shopping
  • depression
  • disturbance in attention
  • fibromyalgia
  • hyperphagia
  • hypersexuality
5 - 10 years:
  • cataract
  • lumbar spinal stenosis
  • cervical spinal stenosis
  • congestive heart failure - left
  • copd
  • dilated cardiomyopathy
  • dizziness
  • erectile dysfunction
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • facet joint syndrome
10+ years:
  • alcohol use
not specified:
  • fall
  • pain
  • weight increased
  • anxiety
  • nausea
  • diabetes mellitus
  • paraesthesia
  • insomnia
  • back pain
  • dyspnoea

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • fall
  • nausea
  • back pain
  • weight increased
  • arthralgia
  • diabetes mellitus
  • injury
  • insomnia
male:
  • restless legs syndrome
  • weight increased
  • cough
  • insomnia
  • dyspnoea
  • fall
  • hypoaesthesia
  • pain
  • chest discomfort
  • paraesthesia

Most common drug interactions by age *:

20-29:
  • nausea
  • anxiety
  • depression
  • emotional disorder
  • gambling
  • gastrooesophageal reflux disease
  • headache
  • hypertension
  • hypoglycaemia
  • insomnia
30-39:
  • pain
  • dyskinesia
  • injury
  • insomnia
  • dry throat
  • dysphagia
  • oropharyngeal pain
  • pharyngitis streptococcal
  • pneumonia
  • pulmonary artery thrombosis
40-49:
  • insomnia
  • anxiety
  • restless legs syndrome
  • irritable bowel syndrome
  • arrhythmia
  • conduction disorder
  • overdose
  • depressed mood
  • drug ineffective
  • panic attack
50-59:
  • dyspnoea
  • nausea
  • headache
  • swelling face
  • swollen tongue
  • urticaria
  • fall
  • vomiting
  • pyrexia
  • syncope
60+:
  • fall
  • pain
  • anxiety
  • pneumonia
  • back pain
  • diabetes mellitus
  • pain in extremity
  • myalgia
  • weight increased
  • cardiac failure congestive

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Allegra and Requip xl?

Can you answer these questions?

More questions for: Allegra, Requip xl

You may be interested in these reviews

More reviews for: Allegra, Requip xl

On eHealthMe, Allegra (fexofenadine hydrochloride) is often used to treat hypersensitivity. Requip xl (ropinirole hydrochloride) is often used to treat parkinson's disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.